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Abstract
Background: The gastrointestinal tract is the primary site of toxin interaction, an interface between the organism
and its surroundings. In this study, we assessed the alteration of intestinal mRNA profile in the case of co-occurrence of
zearalenone (ZEA), a secondary Fusarium metabolite, and Escherichia coli (E. coli), on the intestinal porcine epithelial
cells IPEC-1. We chose this model since the pig is a species which is susceptible to pathogen and mycotoxin
co-exposure.
Results: After treating the cells with the two contaminants, either separately or in combination, the differential
gene expression between groups was assessed, using the microarray technology. Data analysis identified 1691
upregulated and 797 downregulated genes as a response to E. coli exposure, while for ZEA treated cells, 303
genes were upregulated and 49 downregulated. The co-contamination led to 991 upregulated and 800 downregulated
genes. The altered gene expression pattern was further classified into 8 functional groups. In the case of co-exposure to
ZEA and E.coli, a clear increase of proinflammatory mechanisms.
Conclusions: These results demonstrate the complex effect of single or multiple contaminants exposure at cellular and
molecular level, with significant implications that might lead to the activation of pathological mechanisms. A
better understanding of the effects of co-contamination is mandatory in developing novel exposure regulations
and prevention measures.
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Background
The diseases caused by mycotoxin exposure can display
acute or chronic effects, the latter being the result of
low-dose intake over a longer period of time, resulting
in decreased productivity and reduced resistance to
pathogens [1]. Chronic ingestion of mycotoxins is also a
concern relating to the health of human populations [1,
2]. The gastrointestinal tract (GIT) is a major site where
mycotoxins exert their effect, being the primary site of
interaction [3], and as such, is frequently exposed to
various toxic agents. Considering this, during the last
decades the role of this GIT in primary immune defense
has been intensively studied [4, 5].
The rapid uptake of ingested mycotoxins in the circu-
lation points to the fact that these substances are mostly
absorbed in the upper part of the GIT [1, 6]. Also, some
mycotoxins undergo enterohepatic recirculation [1, 2],
thus being present for long times in the intestine [7]. An
effect of mycotoxins on the GIT can be observed even at
concentrations which do not exert any systemic effects,
suggesting that the combination of various mycotoxins
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at non-toxic individual levels may become toxic at intes-
tinal level [6, 8].
Zearalenone (ZEA) is a secondary metabolite of cer-
tain Fusarium species, synthesized through a polyketide
pathway by F. graminearum, F. culmorum, F. equiseti, F.
crookwellense, etc. [9] [10]. These molds are regular con-
taminants of cereal crops worldwide [11]. ZEA contam-
ination almost always co-occurs with other Fusarium
toxins [12], such as deoxynivalenol (DON) or fumonisins
B1, their combination having most likely an enhanced
toxic effect compared to the individual ones [1, 13–15].
ZEA is stable and resistant to standard decontamination
procedures, and can be found in processed cereal prod-
ucts such as beer, flour, soybean and bread [15, 16]. A
particularity of this mycotoxin is that the structure of
ZEA is similar to that of beta-estradiol; therefore it
activates estrogen receptors [15]. This mycotoxin is
frequently involved in reproductive disorders of farm an-
imals, the most susceptible one being the pig, but is also
implicated in human hyperestrogenic syndromes [7, 17].
The exposure to this toxin during pregnancy and later,
during lactation, can have reversible or irreversible ef-
fects on the offspring [18, 19]. Furthermore, the toxin
has been proven to have effects which are independent
of its binding to the estrogen receptors [8], such as
cytotoxicity, genotoxicity, immunotoxicity, and hepato-
toxicity [15, 19]. For example, ZEA induces oxidative
stress in a dose-dependent manner in the Caco-2 cell
line [18], the SHSY-5Y cell line [20], but also in in vivo
conditions [11, 15].
Up to 90 % of this mycotoxin is absorbed in the upper
part of the GIT, and it goes into enterohepatic circula-
tion, as is the case of other mycotoxins [1]. One of the
important roles of the GIT is its function as an immune
barrier. This function is accomplished through a number
of particularities. Firstly, it possesses its own immune
system, and it is estimated that up to 70 % of the im-
mune defenses of the organism are located in the intes-
tine [6, 7]. Secondly, its morphology contributes to its
role as physical barrier through the tight junctions (TJs)
formed mainly by occludin and claudin isoforms, and
gap junctions (GJs) that permit the transfer of ions, nu-
cleotides and other small molecules between adjacent
cells, and are formed primarily by connexins. Last but
not least, the intestinal microbiota plays a very import-
ant role in protecting against pathogen invasion [21].
The physical barrier properties of the intestine can be al-
tered due to defective TJs and GJs. ZEA has been shown
to reduce mRNA levels of occludin and claudin-4, and
also the protein levels of connexin [22]. Therefore, the
purpose of our study was to assess the impact of co-
contamination of ZEA and E. coli at transcriptomic level,
by using a relevant in vitro model for immunotoxicology
[23], intestinal porcine epithelial cells (IPEC-1), and a
custom design microarray experiment. The data were
extrapolated to their human orthologues [24], and ana-
lyzed in the context of human health by using Ingenuity
Pathway Analysis.
Results
Altered gene expression profiles as a response to ZEA
exposure
Differential gene expression profiles for Control samples
(untreated IPEC cells), versus single treatment cells (ZEA
25 μM, E. coli) and co-contaminated cell groups (ZEA + E.
coli) were generated using one-color hybridization (Cy5)
to custom porcine array slides, designed by Genotypic
Technology, India.
During data analysis, for filtering upregulated genes,
we considered a fold > 0.8 and for filtering downregu-
lated genes a fold < − 0.8 in the ZEA treated samples.
Expression fold values are provided in terms of log base
2. The microarray data analysis for the treated cells is
summarized in the supplementary Table S1. In the case
of E. coli treated cells, microarray data analysis identified
1691 upregulated and 797 downregulated genes, for
ZEA treated cells, we observed 303 upregulated and 49
downregulate genes, while co-contamination led to 991
upregulated genes and 800 downregulated transcripts.
The altered gene expression pattern was further classi-
fied into 8 functional groups (Transcription factor, Signal-
ing, Cell signaling, Proliferation, Cytokine, Interleukin,
Inflammatory response, Growth factor). The results for
the individual treatment (ZEA, E. coli) and combined
treatment (ZEA + E. coli) are presented in Table 1.
Gene interaction networks
The network analysis was conducted using Ingenuity
Pathway Analysis software (Qiagen) and showed, in the
case of the combined treatment, an increased activation
of the genes related to a wide range of canonical path-
ways as displayed in Table 2.
The main altered cellular and molecular pathways are
displayed in Table 3.
Figure 1 represents an overlay of the first two net-
works for the case of co-occurrence of ZEA and E. coli.
presents the altered genes involved in immune-related
pathways.
Validation of the genes with an altered expression level
by qRT-PCR
The expression level of three genes, IL-6 (Interleukine
6), IL-8 (Interleukin 8) and TNFα (tumor necrosis factor
alpha) was evaluated by qRT-PCR in order to validate
microarray data for E. coli, ZEA and ZEA + E. coli ex-
posure when compared to untreated cells (control)
(Fig. 2). As housekeeping genes we used β-actin and
CypA (Cyclophilin A). The expression levels for all
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evaluated three genes are in agreement with the micro-
array data, with slight differences in the intensity for FC.
What is important to observe is the expression level
for TNFα for the combined treatment being similar with
the expression level in the case of E. coli exposure.
These suggest the activation of the fine tuning compen-
satory mechanisms, as a measure to contracare the co-
exposure of ZEA+ E. coli.
Discussions
Our study presents valuable information concerning the
molecular effects of co-contamination with ZEA and an-
other important contaminant, the bacterium E. coli. To
our knowledge, there are only few gene profiling studies
that assess the effects of co-contamination at intestinal
mRNA level [1, 25, 26].
Even under normal, physiological conditions, organisms
are exposed to various types of toxins and microbes, ran-
ging from commensal microbiotas to different pathogens.
But, regardless of the type of contaminant, one particular-
ity that stands out is the fact that it is virtually impossible
to find a situation where one organism is contaminated
with only one agent. It is almost always a matter of co-
contamination so, instead of individually looking at the ef-
fects of each toxin/pathogen, it is mandatory to look at
the combined effects of all the agents that have an impact
on the organism at a certain moment [6, 7, 27].
Bacterial contamination was demonstrated to cause
susceptibility to carcinogenesis [28]. The complex effect
of E. coli contamination is sustained also by our micro-
array data. Moreover, E. coli contamination was ob-
served to cause a reduced immune response in vitro
study, and was correlated with an increased absorption
Table 1 Functional classification of differentially expressed genes
Function Name E. coli ZEA ZEA+ E. coli
Up regulated Down regulated Total
Found
Up regulated Down regulated Total
Found
Up regulated Down regulated Total
Found
Transcription factor 146 26 172 16 4 20 125 20 145
Signaling 273 43 316 39 5 44 197 47 244
Cell signaling 25 5 30 2 1 3 17 5 22
Proliferation 170 20 190 20 0 20 122 23 145
Cytokine 74 6 80 4 0 4 40 7 47
Interleukin 82 6 88 2 0 2 39 5 44
Inflammatory response 62 5 67 4 0 4 33 4 37
Growth factor 104 14 118 15 1 16 65 12 77
Table 2 IPA revealed the top canonical pathways altered by exposure to ZEA, E. coli, respectively ZEA+ E. coli
Nr.
Ctr.
NAME E. coli ZEA ZEA + E. coli
p-value Ratio p-value Ratio p-value Ratio
1. iNOS Signaling 1.23E-06 9/44 (0.205) - - - -
2. MIF Regulation of Innate Immunity 7.06E-06 8/41 (0.195) - - - -
3. IL-12 Signaling and Production in Macrophages 8.15E-06 14/135 (0.104) - - - -
4. Glucocorticoid Receptor Signaling 1.12E-05 20/261 (0.077) - - - -
5. JAK/Stat Signaling 1.25E-05 10/72 (0.139) - - - -
6. Renin-Angiotensin Signaling - - 3.47E-05 6/118 (0.051) - -
7. P2Y Purigenic Receptor Signaling Pathway - - 5.73E-05 6.129 (0.047)
8. Ceramide Signaling - - 7.6E-05 5/84 (0.06) - -
9. Melanocyte Development and Pigmentation Signaling - - 8.51E-05 5.86 (0.058) - -
10. Unfolded protein response - - 1.77E-04 4/54 (0.074) - -
11. IL-17A Signaling in Gastric Cells - - - - 1.83E-06 6/25 (0.24)
12. IL-17A Signaling in Fibroblasts - - - - 1.47E-05 6/35 (0.171)
13. Role of Tissue Factor in Cancer - - - - 5.45E-05 9/110 (0.082)
14. PKCθ Signaling In T Lymphocytes - - - - 9.41E-05 9/118 (0.076)
15. T Cell Receptor Signaling - - - - 1.34E-04 8/97 (0.082)
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Table 3 IPA to ranked molecular and cellular functions for exposure to ZEA, E. coli, respectively ZEA+ E. coli
Nr.
Ctr.
NAME E. coli ZEA ZEA + E. coli
p-value # Molecules p-value # Molecules p-value # Molecules
1. Cell Death and Survival 6.17E-14-2.86E-05 190 1.57E-05-9.21E-03 36 1.02E-14-3.07E-05 137
2. Cellular Development 2.30E-13-2.77E-05 180 1.34E-06-8.91E-03 27 6.46E-19-3.72E-05 141
3. Cellular Growth and Proliferation 2.30E-13- 2.77E-05 198 1.34E06-8.91E03 40 7.68E-20-3.72E-05 159
4. Cell Cycle 2.72E-13-2.32E-05 80 - - 1.61E-14-3.63E-05 72
5. Gene Expression 2.11E-12-4.97E-06 119 - - - -
6. Cell –to-cell Signaling and Interacton - - 2.17E-05-9.21E-03 22 - -
7. Cellular Function and Maintenance - - 2.17E-05-9.21E-03 23 - -
8. Cellular Movement - - - - 5.75E-17-3.63E-05 104
Fig. 1 Overlay of the first two networks generated using IPA in the case of co-exposure of ZEA and E. coli. The red genes represent up-regulated
genes and the green ones are downregulated
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rate of mycotoxins [1, 29]. These affect the maintenance
of the physiological status leading to multiple injuries, as
can be observed by the large number of altered genes in
the case of E. coli exposure.
Contamination with mycotoxins is common and virtu-
ally impossible to eradicate, especially in the case of
animal fodder. Therefore, it can be stated that the effects
of these mycotoxin contaminations, like in the case of
ZEA, are observable also in the similar products which
are consumed by humans – for instance different cereal
based foods. If we also take into consideration the fact
that, according to our results – as well as those of others
– co-contamination is not only common, but it produces
serious deleterious effects, our belief is that there is a
stringent need to develop and impose strict regulations,
both at national and European level, to control and
counteract this phenomenon.
E. coli contamination has been shown to increase the
absorption rates for the Fumonisin B1 mycotoxin, while
other Fusarium metabolites were proved to increase the
bacterial proliferation after oral intake of enterotoxigenic
E. coli contaminated food by piglets [30]. The underlying
mechanism seems to be an impairment of the immune
function in these animals [31]. Another experiment de-
scribes an increased colonization of the porcine intestine
by an Extraintestinal Pathogenic E. coli after exposing
pigs to a one-week long diet of fumonisin B1 -contami-
nated food [32]. Reduced antimicrobial activity of beta-
defensins against E. coli infection has been observed fol-
lowing both individual and combination treatment with
ZEA and other Fusarium sp mycotoxins in the IPEC-1 cell
line [33]. It is important see the negative effect of bacterial
contamination, but these effects are more dramatic when
connected with other contaminants like mycotoxins [29].
What is important is to evaluate what the threshold for
the activation of the compensatory mechanism is for con-
tracare single or multiple toxic exposures.
Following mycotoxin ingestion, the susceptibility to in-
testinal pathogen invasion is increased due to multiple
factors [34]. The immune response is impaired as a re-
sult of mycotoxins targeting cells with a high division
rate or altering the cytokine balance [34]. ZEA has been
shown to influence cytokine expression both at the pro-
tein level as well as at mRNA level [4, 35], confirmed
once again by the present study. ZEA had suppressive
effects on the inflammatory response at the mRNA level
in the BEAS-2B bronchial epithelial cell line [36], but
the effect is significantly increased in the presence of E.
coli.
The microarray results that we obtained were extrapo-
lated to human genes, in order to predict the impact of
these environmental agents. Therefore, we were able to
identify the top five altered canonical pathways which
were related to metabolic processes in humans. A recent
study on the various actions of this mycotoxin presents
the immunomodulatory effect of ZEA [8]. In our re-
search, a pathway which caught our attention was the
IL-17(interleukin 17) signaling pathway. The IL-17 fam-
ilies of cytokines have a major role in acute and chronic
inflammatory responses [37]. IL-17A is the most investi-
gated cytokine from this family, having a pro-inflammatory
role in microbial infections, autoimmune diseases, meta-
bolic disorders and cancer [38]. The IL-17 family also has
a major role in activating downstream pathways, including
NFkB [39]. The activation of MAPKs and C/EBPs related
pathways involve antimicrobial peptides, cytokines and
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Fig. 2 Altered gene expression level involved in the modulation of
immune response related pathways for the case of a ZEA exposure,
b E. coli exposure and c co-exposure of ZEA and E. coli. The red
genes represent up-regulated genes and the green ones are down-
regulated (*p < 0.05, ZEA treated cells versus control cells)
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chemokines, significantly activated in the case of the com-
bined treatment. Figure 3 includes genes involved in
tumorigenesis as a result of the co-exposure to the two
contaminants.
In our study, the IPEC-1 cells displayed a particularly
altered gene expression pattern as a result of the con-
taminant exposure. A significantly increased number of
altered genes involved in the innate immune response,
classified in “cytokines”, “interleukins” and “inflamma-
tory response” categories, were shown to be altered
(Table 1). The number of upregulated genes is roughly
tenfold higher than the number of the ones that were
downregulated as a result of the exposure to E. coli,
ZEA, or the two combined. This comes in contradiction
with other studies which found that this particular
mycotoxin had an inhibitory effect on inflammatory re-
sponses mediated by the synthesis of cytokines and che-
mokines responsible for recruiting effector cells. In their
study on human bronchial epithelial cells, So and col-
leagues observed that the mycotoxin ZEA decreased the
immune response to pathogens of bacterial origin, prob-
ably through the modulation of the TLR (toll-like receptor)
signaling pathway. Nonetheless, this apparent incongruity
reconfirms the paradoxical rule of action of mycotoxins in
general, and ZEA in particular, which states that their effect
is dose- and tissue-dependent. Indeed, there are significant
differences between the technical approaches of the two
experiments, in what concern both the tissue type and the
concentration of mycotoxin that was used [17]. Thus, while
we used 25 μM of ZEA on intestinal epithelial cells, So et
al., 2014 used a higher concentration, 40 μM, on human
bronchial epithelial cells. The intestinal epithelial cells rep-
resent the first barrier, the interface between both nutrients
and contaminants on the one hand, and the internal envir-
onment of the body on the other, being among the most
important structures that contribute to the maintenance of
the overall state of equilibrium in the body. On the other
hand, lung epithelium represents the first outpost in the
fight against air-borne pathogens [40].
Exposures to different doses of ZEA show, indeed, dif-
ferent types of immunological modulatory effects, in dir-
ect relation with the tissue that was analyzed. Our team
presented this when conducting a series of experiments
on polymorphonuclear leukocytes isolated from the
blood of piglets, cultivated and treated with different
doses of ZEA, ranging from 1.5 to 10 μM [35]. The
Fig. 3 Altered gene expression level involved in the modulation of cell transformation as result of co-exposure of ZEA and E. coli. The red genes
represent up-regulated genes and the green ones are downregulated
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Fusarium mycotoxin displayed clear influences on the
innate immunity response of pigs, in strong relation to
the particular dose that was used.
Salah-Abbes and colleagues conducted a series of exper-
iments on blood samples, but this time from mice that
were administered 40 mg kg−1 of ZEA, observing that the
mycotoxin has an immunosuppressive effect [41]. Another
example is the study of Ruh et al. on a modified, stable re-
porter cell line derived from murine monocytes and trans-
fected with human estrogen receptor. Using ZEA at a
concentration of 100 nM, they proved that it stimulates
the promoter activity of IL1β [42].
Microarray technology has proved time and again its
capacity to contribute to the characterization of genome-
wide reactions to the exposure to different environmental
contaminants. This was also shown by Parveen and col-
leagues who analyzed the estrogenic effects of ZEA on the
MCF-7 human breast adenocarcinoma cell line, using the
mycotoxin at a concentration of 10 nm, which proved to
be optimal after several cytotoxicity and proliferation tests.
Their results showed that ZEA had a similar estrogenic
behavior as the natural estrogen molecule E2, even at very
low concentrations, and triggered the activation of the
Erk1/2 pathway [42].
Conclusion
The co-occurrence of different contaminants represents
an important issue in human health. The bacterial and
mycotoxin co-occurrence is a fact commonly found in na-
ture. The findings reported in this paper have an applica-
tive research side, serving as knowledge base for assessing
the maximum tolerance level for the ZEA mycotoxin. This
is a simple example of the co-occurrence of two contami-
nants from the components of the exposome and the im-
portant alteration caused at cellular and molecular level.
Therefore is important to evaluate these effects in the
context of co-exposure, as found in real living conditions.
Our study emphasizes the multiple molecular pathways
altered in the case of single and multiple contaminant ex-
posures (ZEA and E. coli). A significant aspect that was
observed is the co-activation of the IL-17 signaling path-
way and of carcinogenic mechanisms, specific for the co-
contamination with E. coli and ZEA. This data emphasizes
the complex effect of this toxin, and supports the idea to
conduct further investigations in the context of co-
exposure with other environmental contaminants.
Methods
Cell cultures and contaminants
For this study we used the primary epithelial cell line
IPEC-1, obtained from the small intestine of a new-born
piglet. The cells were propagated by serial passages, and
incubated at 37 °C and 5 % CO2 in 75 cm
2 flasks using
complete DMEM/F-12 medium (Sigma) with antibiotics
– Penicillin (100UI/mL) and Streptomycin (50 μg/mL),
5 % foetal bovine serum (Sigma), 2 mM L-glutamine,
15 mM Hepes (Sigma), epidermal growth factor (5 μg/L)
(Sigma), insulin (10 μg/mL), transferrin (5 μg/mL) and
sodium selenite (5 ng/mL) (ITS Premix, Sigma). Cells
were seeded at a concentration of 2.0x105 cells/well and
cultivated in 24-well culture plates (Costar Coming, NY,
USA). Complete confluence was obtained after 2–3 days.
This cell based study is in agreement with the inter-
national tendency on replacement, refinement and re-
duction the animal based studies.
Cell treatment
A solution of ZEA powder was prepared in ethanol/cul-
ture medium (1:1), then aliquoted and kept at −20 °C,
and diluted in cell culture medium to assess the cellular
and molecular impact.
E. coli preparation
The K88 Enterotoxigenic Escherichia coli (ETEC O149)
strain was used for this study. The bacteria were incu-
bated overnight in Luria-Bertani medium (Lysogeny
broth - LB) in polystyrene tubes at 37 °C and 190 rpm
shaking as described by Roselli et al., (2003), then di-
luted in fresh broth (1:100) and incubated for 4 h. In
order to determine bacterial concentration, the absorb-
ance/optical density at 600 nm was measured (OD600).
The broth was centrifuged at 4000 rpm for 10 min and
the E. coli was harvested and resuspended in PBS. Fol-
lowing the adjustment of concentration, bacteria were
used in the IPEC-1 cell assay.
Bacterial and mycotoxin co-contamination
After reaching 70-80 % confluence, the IPEC-1 mono-
layers were treated with E. coli (7.0x106 CFU/ml), or
25 μM of ZEA, or a combination of the two. Distribu-
tion of the treatments was as follows: (1) control, (2)
ZEA, (3) E. coli, (4) ZEA + E. coli. The treated cells were
incubated for 24 h, bacteria were removed by washing,
and then the cells recuperated in 0.8 ml of TRIzol Re-
agent (TermoFisher Scientific, Catalog number: 15596–
026), then stored at -80C until further processing for
RNA extraction, quality control and, finally, microarray
evaluation.
Microarray slide preparation
The microarray experiment was conducted using the
SurePrint G3 Custom Gene Expression Microarray
8x60K (G4102A, S. scrofa) custom slides. The micro-
array probes (cRNA-Cy5) were synthesized from equal
quantities of 500 ng total RNA, using the Agilent Low
Input Quick Amp Labeling Kit (5190–2305) based on
the manufacturer’s recommended protocol, followed by
a purification step with RNeasy Mini Kit (Qiagen).
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cRNA-Cy5 quality control was conducted using Nano-
Drop ND-1000 spectrophotometer, showing a minimal
yield of 1.6 μg and a specific activity of 6 pmol/μl Cy5/
μg cRNA. The fragmentation and hybridization steps
followed the classical Agilent protocol. After a washing
step, the slides were scanned on Agilent Microarray
Scanner G2565BA for low and high resolution.
Statistical analyses of microarray data
The samples were grouped based on the replicates and
the data was analyzed. The pre-processing, normalization
and differential analysis of data were done using the Gene-
Spring GX version 12.6.1 software by the Genotypic Tech-
nology team, and the data were uploaded on the
ARRAYEXPRESS database (ID: E-MTAB-3885). Lowes
normalization was used to adjust the differences in inten-
sities of the Cy5 by applying a smoothing adjustment that
removes such variation. The analyses identified significant
genes that were up- and down-regulated in the test sam-
ples (ZEA 25 μM) compared to the controls. Statistical p-
value was assessed by applying Student’s t-test correlated
with the false discovery rate (FDR – Benjamini Hochberg)
correction for evaluating the impact of single and multiple
compounds exposure. We considered a threshold greater
and lower that 0.8 for Geomean fold for the relative gene
expression level, and a p-value smaller than 0.05. Using
GeneSpring GX Software, genes were classified according
to their functionality. In order to infer the effects of ZEA
and E. coli on human health, all the transcript sequences
of Sus scrofa were extrapolated to their human counter-
parts using Homology Based Annotation retrieved from
NCBI Database (www.ncbi.nlm.nih.gov), and BLAST. In-
genuity Pathway Analysis (IPA; htp://www.ingenuity.com)
was applied to evaluate the impact on the biological net-
works that were altered as a response to different treat-
ment scenarios.
qRT-PCR data validation
In order to validate the microarray data, we arbitrarily
selected three genes (IL-6, IL-8 and TNFα) for which we
performed qRT-PCR. For the cDNA synthesis, we used
an amount of 1000 ng total RNA using M-MLV Reverse
Transcriptase kit (Invitrogen, Life Technologies). qRT-
PCR was conducted following the method previously de-
scribed by Taranu et al., 2014 [4].
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